1. Home
  2. IQV vs SYF Comparison

IQV vs SYF Comparison

Compare IQV & SYF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

N/A

Current Price

$183.57

Market Cap

28.6B

Sector

Health Care

ML Signal

N/A

SYF

Synchrony Financial

N/A

Current Price

$70.55

Market Cap

25.5B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
IQV
SYF
Founded
1982
1932
Country
United States
United States
Employees
93000
20000
Industry
Biotechnology: Commercial Physical & Biological Resarch
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
28.6B
25.5B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
IQV
SYF
Price
$183.57
$70.55
Analyst Decision
Strong Buy
Buy
Analyst Count
16
19
Target Price
$227.13
$84.83
AVG Volume (30 Days)
1.5M
3.6M
Earning Date
05-05-2026
04-21-2026
Dividend Yield
N/A
1.60%
EPS Growth
4.67
N/A
EPS
1.61
N/A
Revenue
$9,739,000,000.00
N/A
Revenue This Year
$6.77
$84.92
Revenue Next Year
$5.89
$5.11
P/E Ratio
$113.94
$7.85
Revenue Growth
41.60
N/A
52 Week Low
$153.23
$59.46
52 Week High
$247.05
$88.77

Technical Indicators

Market Signals
Indicator
IQV
SYF
Relative Strength Index (RSI) 58.16 44.79
Support Level $176.99 $69.04
Resistance Level $191.78 $75.15
Average True Range (ATR) 6.97 1.83
MACD 1.22 -0.07
Stochastic Oscillator 78.91 41.73

Price Performance

Historical Comparison
IQV
SYF

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

About SYF Synchrony Financial

Synchrony Financial, originally a spinoff of GE Capital's retail financing business, is the largest provider of private-label credit cards in the United States by both outstanding receivables and purchasing volume. Synchrony partners with other firms to market its credit products in their physical stores as well as on their websites and mobile applications. Synchrony operates through three segments: retail card (private-label and co-branded general-purpose credit cards), payment solutions (promotional financing for large ticket purchases), and CareCredit (financing for elective healthcare procedures).

Share on Social Networks: